{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:48:17Z","timestamp":1789868897851,"version":"4.0.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,9,1]]},"DOI":"10.1093\/jac\/dkh397","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T00:16:39Z","timestamp":1091664999000},"page":"628-633","source":"Crossref","is-referenced-by-count":88,"title":["Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum \u03b2-lactamases in York, UK"],"prefix":"10.1093","volume":"54","author":[{"given":"C. J.","family":"Munday","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. J.","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Hawkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,9]]},"reference":[{"key":"key\n\t\t\t\t20171010225050_R1","doi-asserted-by":"crossref","unstructured":"Livermore, D. M. (1995). \u03b2-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews8, 557\u201384.","DOI":"10.1128\/CMR.8.4.557"},{"key":"key\n\t\t\t\t20171010225050_R2","doi-asserted-by":"crossref","unstructured":"Brenwald, N. P., Jevons, G., Andrews, J. M. et al. (2003). An outbreak of a CTX-M-type \u03b2-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum \u03b2-lactamases. Journal of Antimicrobial Chemotherapy51, 195\u20136.","DOI":"10.1093\/jac\/dkg051"},{"key":"key\n\t\t\t\t20171010225050_R3","doi-asserted-by":"crossref","unstructured":"Mushtaq, S., Woodford, N., Potz, N. et al. (2003). Detection of CTX-M-15 extended-spectrum \u03b2-lactamase in the United Kingdom. Journal of Antimicrobial Chemotherapy52, 528\u20139.","DOI":"10.1093\/jac\/dkg353"},{"key":"key\n\t\t\t\t20171010225050_R4","doi-asserted-by":"crossref","unstructured":"Bonnet, R. (2004). Growing group of extended-spectrum \u03b2-lactamases: the CTX-M enzymes. Antimicrobial Agents and Chemotherapy48, 1\u201314.","DOI":"10.1128\/AAC.48.1.1-14.2004"},{"key":"key\n\t\t\t\t20171010225050_R5","doi-asserted-by":"crossref","unstructured":"Piddock, L. J., Walters, R. N., Jin, Y. F. et al. (1997). Prevalence and mechanism of resistance to \u2018third-generation\u2019 cephalosporins in clinically relevant isolates of Enterobacteriaceae from 43 hospitals in the UK, 1990\u20131991. Journal of Antimicrobial Chemotherapy39, 177\u201387.","DOI":"10.1093\/jac\/39.2.177"},{"key":"key\n\t\t\t\t20171010225050_R6","doi-asserted-by":"crossref","unstructured":"Munday, C. J., Xiong, J., Li, C. et al. (2004). Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China. International Journal of Antimicrobial Agents23, 175\u201380.","DOI":"10.1016\/j.ijantimicag.2003.07.004"},{"key":"key\n\t\t\t\t20171010225050_R7","doi-asserted-by":"crossref","unstructured":"Radice, M., Power, P., Di Conza, J. et al. (2002). Early dissemination of CTX-M-derived enzymes in South America. Antimicrobial Agents and Chemotherapy46, 602\u20134.","DOI":"10.1128\/AAC.46.2.602-604.2002"},{"key":"key\n\t\t\t\t20171010225050_R8","doi-asserted-by":"crossref","unstructured":"Quinteros, M., Radice, M., Gardella, N. et al. (2003). Extended-spectrum \u03b2-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrobial Agents and Chemotherapy47, 2864\u20137.","DOI":"10.1128\/AAC.47.9.2864-2867.2003"},{"key":"key\n\t\t\t\t20171010225050_R9","doi-asserted-by":"crossref","unstructured":"Alobwede, I., M'Zali, F. H., Livermore, D. M. et al. (2003). CTX-M extended-spectrum \u03b2-lactamase arrives in the UK. Journal of Antimicrobial Chemotherapy51, 470\u20131.","DOI":"10.1093\/jac\/dkg096"},{"key":"key\n\t\t\t\t20171010225050_R10","doi-asserted-by":"crossref","unstructured":"Jarlier, V., Nicolas, M. H., Fournier, G. et al. (1988). Extended broad-spectrum \u03b2-lactamases conferring transferable resistance to newer \u03b2-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews in Infectious Diseases10, 867\u201378.","DOI":"10.1093\/clinids\/10.4.867"},{"key":"key\n\t\t\t\t20171010225050_R11","unstructured":"Hawkey, P. M. & Lewis, D. (2004). Medical Bacteriology\u2014A Practical Approach, 2nd edn. Oxford University Press, Oxford, UK."},{"key":"key\n\t\t\t\t20171010225050_R12","doi-asserted-by":"crossref","unstructured":"Andrews, J. M. (2001). BSAC standardized disc susceptibility testing method. Journal of Antimicrobial Chemotheraphy48, Suppl. S1, 43\u201357.","DOI":"10.1093\/jac\/48.suppl_1.43"},{"key":"key\n\t\t\t\t20171010225050_R13","unstructured":"National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically\u2014Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171010225050_R14","unstructured":"National Committee for Clinical Performance Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing: Approved Standard M100-S12. NCCLS, Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171010225050_R15","doi-asserted-by":"crossref","unstructured":"Colom, K., Perez, J., Alonso, R. et al. (2003). Simple and reliable multiplex PCR assay for detection of blaTEM, blaSHV and blaOXA-1 genes in Enterobacteriaceae. FEMS Microbiological Letters223, 147\u201351.","DOI":"10.1016\/S0378-1097(03)00306-9"},{"key":"key\n\t\t\t\t20171010225050_R16","doi-asserted-by":"crossref","unstructured":"Chanawong, A., M'Zali, F. H., Heritage, J. et al. (2001). Discrimination of SHV \u03b2-lactamase genes by restriction site insertion-PCR. Antimicrobial Agents and Chemotherapy45, 2110\u20134.","DOI":"10.1128\/AAC.45.7.2110-2114.2001"},{"key":"key\n\t\t\t\t20171010225050_R17","unstructured":"Munday, C. J., Ensor, V. M., Liu, W. E. et al. (2004). Multiplex PCR detection of CTX-M gene. Clinical Microbiology and Infection10, Suppl. 3, 248."},{"key":"key\n\t\t\t\t20171010225050_R18","doi-asserted-by":"crossref","unstructured":"Sabate, M., Navarro, F., Miro, E. et al. (2002). Novel complex sul1-type integron in Escherichia coli carrying blaCTX-M-9. Antimicrobial Agents and Chemotherapy46, 2656\u201361.","DOI":"10.1128\/AAC.46.8.2656-2661.2002"},{"key":"key\n\t\t\t\t20171010225050_R19","doi-asserted-by":"crossref","unstructured":"Yamasaki, K., Komatsu, M., Yamashita, T. et al. (2003). Production of CTX-M-3 extended-spectrum \u03b2-lactamase and IMP-1 metallo \u03b2-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan. Journal of Antimicrobial Chemotherapy51, 631\u20138.","DOI":"10.1093\/jac\/dkg103"},{"key":"key\n\t\t\t\t20171010225050_R20","doi-asserted-by":"crossref","unstructured":"Yu, W. L., Winokur, P. L., Von Stein, D. L. et al. (2002). First description of Klebsiella pneumoniae harboring CTX-M \u03b2-lactamases (CTX-M-14 and CTX-M-3) in Taiwan. Antimicrobial Agents and Chemotherapy46, 1098\u2013100.","DOI":"10.1128\/AAC.46.4.1098-1100.2002"},{"key":"key\n\t\t\t\t20171010225050_R21","doi-asserted-by":"crossref","unstructured":"Canton, R., Oliver, A., Coque, T. M. et al. (2002). Epidemiology of extended-spectrum \u03b2-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. Journal of Clinical Microbiology40, 1237\u201343.","DOI":"10.1128\/JCM.40.4.1237-1243.2002"},{"key":"key\n\t\t\t\t20171010225050_R22","doi-asserted-by":"crossref","unstructured":"Chanawong, A., M'Zali, F. H., Heritage, J. et al. (2001). SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum beta-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. Journal of Antimicrobial Chemotherapy48, 839\u201352.","DOI":"10.1093\/jac\/48.6.839"},{"key":"key\n\t\t\t\t20171010225050_R23","doi-asserted-by":"crossref","unstructured":"Eckert, C., Gautier, V., Saladin-Allard, M. et al. (2004). Dissemination of CTX-M-type \u03b2-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrobial Agents and Chemotherapy48, 1249\u201355.","DOI":"10.1128\/AAC.48.4.1249-1255.2004"},{"key":"key\n\t\t\t\t20171010225050_R24","doi-asserted-by":"crossref","unstructured":"Chanawong, A., M'Zali, F. H., Heritage, J. et al. (2002). Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrobial Agents and Chemotherapy46, 630\u20137.","DOI":"10.1128\/AAC.46.3.630-637.2002"},{"key":"key\n\t\t\t\t20171010225050_R25","doi-asserted-by":"crossref","unstructured":"Mulvey, M. R., Bryce, E., Boyd, D. et al. (2004). Ambler class A extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrobial Agents and Chemotherapy48, 1204\u201314.","DOI":"10.1128\/AAC.48.4.1204-1214.2004"},{"key":"key\n\t\t\t\t20171010225050_R26","doi-asserted-by":"crossref","unstructured":"Paterson, D. L., Hujer, K. M., Hujer, A. M. et al. (2003). Extended-spectrum \u03b2-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type \u03b2-lactamases. Antimicrobial Agents and Chemotherapy47, 3554\u201360.","DOI":"10.1128\/AAC.47.11.3554-3560.2003"},{"key":"key\n\t\t\t\t20171010225050_R27","doi-asserted-by":"crossref","unstructured":"Mulvey, M. R., Soule, G., Boyd, D. et al. (2003). Characterization of the first extended-spectrum \u03b2-lactamase-producing Salmonella isolate identified in Canada. Journal of Clinical Microbiology41, 460\u20132.","DOI":"10.1128\/JCM.41.1.460-462.2003"},{"key":"key\n\t\t\t\t20171010225050_R28","doi-asserted-by":"crossref","unstructured":"Baraniak, A., Sadowy, E., Hryniewicz, W. et al. (2002). Two different extended-spectrum \u03b2-lactamases (ESBLs) in one of the first ESBL-producing salmonella isolates in Poland. Journal of Clinical Microbiology40, 1095\u20137.","DOI":"10.1128\/JCM.40.3.1095-1097.2002"},{"key":"key\n\t\t\t\t20171010225050_R29","doi-asserted-by":"crossref","unstructured":"Miriagou, V., Filip, R., Coman, G. et al. (2002). Expanded-spectrum cephalosporin-resistant salmonella strains in Romania. Journal of Clinical Microbiology40, 4334\u20136.","DOI":"10.1128\/JCM.40.11.4334-4336.2002"},{"key":"key\n\t\t\t\t20171010225050_R30","doi-asserted-by":"crossref","unstructured":"Villa, L., Mammina, C., Miriagou, V. et al. (2002). Multidrug and broad-spectrum cephalosporin resistance among Salmonella enterica serotype Enteritidis clinical isolates in southern Italy. Journal of Clinical Microbiology40, 2662\u20135.","DOI":"10.1128\/JCM.40.7.2662-2665.2002"},{"key":"key\n\t\t\t\t20171010225050_R31","doi-asserted-by":"crossref","unstructured":"Romero, L., Lopez, L., Martinez-Martinez, L. et al. (2004). Characterization of the first CTX-M-14-producing Salmonella enterica serotype Enteritidis isolate. Journal of Antimicrobial Chemotherapy53, 1113\u20134.","DOI":"10.1093\/jac\/dkh246"},{"key":"key\n\t\t\t\t20171010225050_R32","doi-asserted-by":"crossref","unstructured":"Daza, R., Gutierrez, J. & Piedrola, G. (2001). Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. International Journal of Antimicrobial Agents18, 211\u20135.","DOI":"10.1016\/S0924-8579(01)00389-2"},{"key":"key\n\t\t\t\t20171010225050_R33","doi-asserted-by":"crossref","unstructured":"Colodner, R., Rock, W., Chazan, B. et al. (2004). Risk factors for the development of extended-spectrum \u03b2-lactamase-producing bacteria in nonhospitalized patients. European Journal of Clinical Microbiology and Infectious Diseases23, 163\u20137.","DOI":"10.1007\/s10096-003-1084-2"},{"key":"key\n\t\t\t\t20171010225050_R34","unstructured":"Borer, A., Gilad, J., Menashe, G. et al. (2002). Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel. Medical Science Monitor8, CR44-7."},{"key":"key\n\t\t\t\t20171010225050_R35","doi-asserted-by":"crossref","unstructured":"Arpin, C., Dubois, V., Coulange, L. et al. (2003). Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrobial Agents and Chemotherapy47, 3506\u201314.","DOI":"10.1128\/AAC.47.11.3506-3514.2003"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/54\/3\/628\/2222945\/dkh397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T22:42:06Z","timestamp":1585867326000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/54\/3\/628\/742065\/Predominance-and-genetic-diversity-of-community"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,1]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,9]]},"published-print":{"date-parts":[[2004,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh397","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,9]]},"published":{"date-parts":[[2004,9,1]]}}}